Trials / Completed
CompletedNCT06237959
Evaluate the Efficacy and Safety of Proso Millet and Wheat Extract(Keranat™) on Hair Health
A 24-Week, Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of Proso Millet and Wheat Extract(Keranat™) on Hair Health
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Nutracore · Industry
- Sex
- All
- Age
- 19 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this randomized, double-blind, placebo-controlled study will be to evaluate whether the daily intake of Keranat™ for 24 weeks can promote the gloss and elasticity of hairs, improve their density and strength, and reduce hair loss.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Keranat™ | 300 mg/capsule(proso millet and wheat extract 600 mg/day) |
| DIETARY_SUPPLEMENT | placebo | 300 mg/capsule(600 mg/day as placebo) |
Timeline
- Start date
- 2022-11-02
- Primary completion
- 2023-06-12
- Completion
- 2023-12-11
- First posted
- 2024-02-02
- Last updated
- 2024-02-02
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06237959. Inclusion in this directory is not an endorsement.